XAVOTIR SINDROMI RIVOJLANISHIDA QANDLI DIABETNING AHAMIYATI
Main Article Content
Аннотация:
Xavotir sindromi rivojlanishida qandli diabetning ahamiyatini o’rganish
Article Details
Как цитировать:
Библиографические ссылки:
AmetovA.S. Saxarniy diabet 2 tipa.-M.- 2013.- 187 s.
Gulinskaya, O.V. Syrkunov V.M. Insulinorezistentnost u patsiyentov s VICh-infeksiyey // Sovremennye problemy infeksionnoy patologii cheloveka. – Minsk, - 2016. - S.75-78.
Kristina X.R., Yurgen K.R. VICh 2014/2015. – Berlin, 2015.- 917s.
Levi D. E. VICh i patogenez SPIDa. -Perevod 3-go izdaniya. M.: Nauchniy Mir, 2016. – 736s.
Libman G. VICh infeksiya: rukovodstvo.-M.:Geotar-media, 2013.-560s.
Pokrovskiy V.V. VICh-infeksiya i SPID.Natsionalnoye rukovodstvo. .-M.:Geotar-media, 2018.-528s
Alter G., Heckerman D., Schneidewind A. et al. HIV-1 adaptation to NK-cell-mediated immune pressure //Nature.- 2014.-Р.76-79.
American Diabetes Association. “Standards of medical care in diabetes – 2018 abridges for primary care providers”/ Clinical Diabetes 36.1 (2018):14-37.
Davies, Melanie J. et al. “Management of hyperglycaemia in type 2 diabetes,2018. A consensus report by the American Diabetes Association (ADA) and the EASD”. Diabetologia (2018):1-38.
Ledwaba L, Tavel AJ, Paul Khabo P et al. Pre-ART Levels of Inflammation and Coagulation Marfers Are Strong Predictors of Death in a South African Cohort with Advanced HIV Disease.//PLoS One.